FDA Approves Clindamycin Liquid for Dogs and Cats, Updates Sponsor's Address

Summary

The FDA is updating its animal drug regulations to reflect the approval of an abbreviated new animal drug application for clindamycin hydrochloride liquid, which will be used to treat bacterial infections in dogs and cats, and also includes a change of address for the sponsor, Delmarva Laboratories, Inc.